共 50 条
- [41] Comment on “Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double‑blind placebo controlled clinical trial” World Journal of Urology, 2022, 40 : 2585 - 2586
- [42] A randomized-placebo controlled pilot study of tamsulosin, naproxen, and combination in category IIIa/IIIb chronic prostatitis/chronic pelvic pain syndrome JOURNAL OF UROLOGY, 2005, 173 (04): : 30 - 30
- [43] THE ROLE OF MEPARTRICIN IN CATEGORY III CHRONIC NONBACTERIAL PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME (CPPS): A RANDOMIZED PROSPECTIVE PLACEBO-CONTROLLED TRIAL. JOURNAL OF UROLOGY, 2010, 183 (04): : E311 - E311
- [45] Issues in designing a randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome: Comment on Wang et al. Randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome. Int Urol Nephrol. 2016;48:13-18 INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (03) : 457 - 458
- [46] Phenotypically Directed Multimodal Therapy for Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Prospective Study Using UPOINT Editorial Comment JOURNAL OF UROLOGY, 2010, 184 (06): : 2348 - 2349